Seroepidemiologic study of antibody to adult T-cell leukemia virus in Okinawa, Japan. NLM AIDSLINE Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Seroepidemiologic study of antibody to adult T-cell leukemia virus in Okinawa, Japan.

Am J Epidemiol. 1986 Jan;123(1):41-7. Unique Identifier : AIDSLINE MED/86074132
Kajiyama W; Kashiwagi S; Nomura H; Ikematsu H; Hayashi J; Ikematsu W

Abstract: From 1980 to 1984, a total of 3,978 serum samples were collected from healthy subjects in the Yaeyama District of Okinawa, Japan. These serum samples were tested for presence of antibody to adult T-cell leukemia-associated antigen (anti-ATLA) by the enzyme-linked immunosorbent assay (ELISA) method. Overall prevalence of anti-ATLA was 15.3%. Standardized prevalence differed from island to island: Hateruma Island had the highest (21.2%) and Taketomi Island the lowest (6.2%). Prevalence of anti-ATLA increased with age and was significantly higher in females (18.1%) than in males (12.2%) (p less than 0.001). For subjects younger than 20 years of age, the rate of anti-ATLA in males was slightly higher than that in females. For subjects 20 years of age and over, prevalence was higher in females than in males. In all age groups 40 years and over, prevalence was significantly higher in females than in males.
Keywords: Adolescence Adult Age Factors Aged Antibodies, Viral/*IMMUNOLOGY/ISOLATION & PURIF Child Child, Preschool Enzyme-Linked Immunosorbent Assay Epidemiologic Methods Female Human HTLV-BLV Viruses/*IMMUNOLOGY Infant Japan Male Middle Age Retroviridae Infections/BLOOD/EPIDEMIOLOGY/IMMUNOLOGY Sex Factors JOURNAL ARTICLE

KWDadolescenceadultagefactorsagedantibodies,viral/KWDimmunology/isolation&purifchildchild,preschoolenzyme-linkedimmunosorbentassayepidemiologicmethodsfemalehumanhtlv-blvviruses/KWDimmunologyinfantjapanmalemiddleageretroviridaeinfections/blood/epidemiology/immunologysexfactorsjournalarticle
860330
M8630039

Copyright © 1986 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .